(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÃO FARMACÊUTICA DE ANTICORPO ANTI-PD-1 E USO DA MESMA

ArquivadaInvention PatentPCT · CN2021109438
Talk to an expert

Application data

Number

112023001471

Type

Invention Patent

Filing

07/30/2021

Publication

03/14/2023

PCT

CN2021109438
View on INPI

Progress at the INPI

  1. Filing07/30/21
  2. Publication03/14/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 07/30/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/22/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.

CN

SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.

CN

See this company's full portfolio

Inventors

X. M. (pessoa física)

CN

X. L. (pessoa física)

CN

Z. Y. (pessoa física)

CN

Technical data

IPC Classification

A61K 39/395A61P 35/00

Priority claims

CN

202010755954.9 · 07/31/2020

CN

202110831575.8 · 07/22/2021

Abstract

COMPOSIÇÃO FARMACÊUTICA DE ANTICORPO ANTI-PD-1 E USO DA MESMA. A presente invenção refere-se a uma composição farmacêutica de anticorpo anti-PD-1 e uso da mesma. Especificamente, a presente invenção refere-se a uma composição farmacêutica compreendendo um anticorpo anti-PD-1 e uma solução tampão.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/22/2024

RPI 2807

Arquivamento - Art. 33 da LPI

#11.1

08/06/2024

RPI 2796

Notificação de entrada na fase nacional - PCT

#1.3

03/14/2023

RPI 2723

Alteração de dados cadastrais

#1.1

02/07/2023

RPI 2718

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.